AbCellera Biologics (ABCL) Debt to Equity (2020 - 2025)
AbCellera Biologics (ABCL) reported Debt to Equity of $0.01 for Q1 2025, down 81.16% on a YoY basis from $0.05 in Q1 2024, and up 11.97% quarter-over-quarter from $0.01 in Q4 2024.
AbCellera Biologics (ABCL) Debt to Equity (2020 - 2025) Analysis & Trends
AbCellera Biologics has reported Debt to Equity for 6 years, with the latest figure at $0.01 in Q1 2025.
- For the quarter ending Q1 2025, Debt to Equity fell 81.16% year-over-year to $0.01; the trailing twelve-month figure through Mar 2025 stood at $0.01 (down 81.16% YoY), and the FY2024 full-year result was $0.01, down 82.52% from the prior year.
- Debt to Equity for Q1 2025 stood at $0.01, up from $0.01 in the prior quarter.
- The five-year high for Debt to Equity was $0.05 in Q2 2023, with the low at $0.01 in Q4 2024.
- Historically, Debt to Equity has averaged $0.03 across 5 years, with a median of $0.02 in 2022.
- Annual changes were most pronounced in 2022 — Debt to Equity surged 136.16% — and 2024, when it tumbled 82.52%.
- AbCellera Biologics' Debt to Equity stood at $0.02 in 2021, then surged by 60.33% to $0.04 in 2022, then climbed by 22.19% to $0.04 in 2023, then sank by 82.52% to $0.01 in 2024, then rose by 11.97% to $0.01 in 2025.
- The last three Debt to Equity figures came in at $0.01 (Q1 2025), $0.01 (Q4 2024), and $0.02 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 0.32 |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | AbCellera Biologics | 1.55 Bn | 1.44 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.05 |
| Dec 31, 2023 | 0.04 |
| Sep 30, 2023 | 0.05 |
| Jun 30, 2023 | 0.05 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.04 |
| Sep 30, 2022 | 0.03 |
| Jun 30, 2022 | 0.03 |
| Mar 31, 2022 | 0.02 |
| Dec 31, 2021 | 0.02 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |
| Dec 31, 2020 | 0.02 |